Bank of New York Mellon’s NRC Health Common Stock NRC Stock Holding History

Bank of New York Mellon’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.44M	Buy	252,235 +1,528	+0.6%	+$28.4K	﹤0.01%	2395
2026 Q1	$4.26M	Buy	250,707 +9,730	+4%	+$165K	﹤0.01%	2409
2025 Q4	$4.52M	Buy	240,977 +40,286	+20%	+$608K	﹤0.01%	2380
2025 Q3	$2.56M	Sell	200,691 -3,883	-2%	-$58.2K	﹤0.01%	2672
2025 Q2	$3.44M	Sell	204,574 -4,623	-2%	-$62.5K	﹤0.01%	2481
2025 Q1	$2.68M	Sell	209,197 -8,015	-4%	-$129K	﹤0.01%	2545
2024 Q4	$3.83M	Buy	217,212 +101,957	+88%	+$1.93M	﹤0.01%	2427
2024 Q3	$2.63M	Sell	115,255 -8,000	-6%	-$181K	﹤0.01%	2617
2024 Q2	$2.83M	Buy	123,255 +6,295	+5%	+$194K	﹤0.01%	2605
2024 Q1	$4.63M	Sell	116,960 -4,979	-4%	-$197K	﹤0.01%	2361
2023 Q4	$4.82M	Sell	121,939 -9,172	-7%	-$384K	﹤0.01%	2387
2023 Q3	$5.82M	Sell	131,111 -7	-0%	-$305	﹤0.01%	2235
2023 Q2	$5.7M	Sell	131,118 -548	-0.4%	-$24.1K	﹤0.01%	2247
2023 Q1	$5.73M	Buy	131,666 +1,474	+1%	+$65.1K	﹤0.01%	2228
2022 Q4	$4.86M	Buy	130,192 +36,476	+39%	+$1.41M	﹤0.01%	2357
2022 Q3	$3.73M	Buy	93,716 +4,778	+5%	+$177K	﹤0.01%	2460
2022 Q2	$3.4M	Sell	88,938 -1,445	-2%	-$52.3K	﹤0.01%	2529
2022 Q1	$3.58M	Buy	90,383 +1,776	+2%	+$69.5K	﹤0.01%	2598
2021 Q4	$3.68M	Buy	88,607 +32,079	+57%	+$1.39M	﹤0.01%	2624
2021 Q3	$2.38M	Buy	56,528 +2,703	+5%	+$136K	﹤0.01%	2883
2021 Q2	$2.47M	Sell	53,825 -9,291	-15%	-$442K	﹤0.01%	2857
2021 Q1	$2.96M	Sell	63,116 -932	-1%	-$45.3K	﹤0.01%	2697
2020 Q4	$2.74M	Buy	64,048 +6,036	+10%	+$310K	﹤0.01%	2664
2020 Q3	$2.85M	Sell	58,012 -46,860	-45%	-$2.59M	﹤0.01%	2480
2020 Q2	$6.1M	Sell	104,872 -1,022	-1%	-$54K	﹤0.01%	2119
2020 Q1	$4.82M	Sell	105,894 -7,866	-7%	-$473K	﹤0.01%	2096
2019 Q4	$7.5M	Sell	113,760 -20,653	-15%	-$1.26M	﹤0.01%	2136
2019 Q3	$7.76M	Sell	134,413 -81	-0.1%	-$5.02K	﹤0.01%	2064
2019 Q2	$7.75M	Buy	134,494 +7,589	+6%	+$351K	﹤0.01%	2105
2019 Q1	$4.9M	Buy	126,905 +601	+0.5%	+$23.5K	﹤0.01%	2343
2018 Q4	$4.82M	Sell	126,304 -3,503	-3%	-$135K	﹤0.01%	2318
2018 Q3	$5.01M	Buy	129,807 +2,933	+2%	+$111K	﹤0.01%	2414
2018 Q2	$4.74M	Buy	126,874 +31,488	+33%	+$1.1M	﹤0.01%	2417
2018 Q1	$2.79M	Sell	95,386 -1,063	-1%	-$35.7K	﹤0.01%	2640
2017 Q4	$3.6M	Buy	96,449 +164	+0.2%	+$5.82K	﹤0.01%	2514
2017 Q3	$3.63M	Sell	96,285 -233	-0.2%	-$7.32K	﹤0.01%	2494
2017 Q2	$2.6M	Sell	96,518 -1,906	-2%	-$46.6K	﹤0.01%	2693
2017 Q1	$1.94M	Buy	98,424 +1,311	+1%	+$24.2K	﹤0.01%	2873
2016 Q4	$1.84M	Buy	97,113 +13,075	+16%	+$216K	﹤0.01%	2902
2016 Q3	$1.37M	Buy	84,038 +980	+1%	+$15.4K	﹤0.01%	3000
2016 Q2	$1.14M	Buy	83,058 +9,833	+13%	+$139K	﹤0.01%	3057
2016 Q1	$1.14M	Buy	73,225 +5,558	+8%	+$81.5K	﹤0.01%	2981
2015 Q4	$1.08M	Buy	67,667 +23,987	+55%	+$364K	﹤0.01%	3122
2015 Q3	$522K	Sell	43,680 -8,727	-17%	-$116K	﹤0.01%	3570
2015 Q2	$745K	Buy	52,407 +471	+0.9%	+$6.67K	﹤0.01%	3489
2015 Q1	$748K	Sell	51,936 -50	-0.1%	-$707	﹤0.01%	3448
2014 Q4	$727K	Sell	51,986 -857	-2%	-$12.6K	﹤0.01%	3468
2014 Q3	$687K	Buy	52,843 +1,776	+3%	+$24.4K	﹤0.01%	3504
2014 Q2	$715K	Sell	51,067 -1,392	-3%	-$20.9K	﹤0.01%	3486
2014 Q1	$871K	Sell	52,459 -269	-0.5%	-$4.5K	﹤0.01%	3352
2013 Q4	$993K	Sell	52,728 -3,539	-6%	-$62.1K	﹤0.01%	3314
2013 Q3	$1.06M	Buy	56,267 +4,449	+9%	+$76.4K	﹤0.01%	3211
2013 Q2	$932K	Buy	+51,818	New	+$827K	﹤0.01%	3232

Other funds holding NRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Bank of New York Mellon's NRC Position: Q2 2026 in Review

Bank of New York Mellon increased its NRC Health Common Stock (NRC) stake by 0.61% in Q2 2026, buying an estimated $28.4K and bringing the position to 252,235 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Bank of New York Mellon first reported a position in NRC in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.76M in Q3 2019. 49 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Bank of New York Mellon held 252,235 shares of NRC Health Common Stock worth $5.44M as of Q2 2026.
Bank of New York Mellon bought 1,528 NRC Health Common Stock shares in Q2 2026, an estimated $28.4K.
NRC Health Common Stock made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2395 holding.
Bank of New York Mellon first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's NRC Health Common Stock position peaked at $7.76M in Q3 2019.
49 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.